← European Medicine Shortage Tracker · all medicines

Dibromopropamidine isethionate shortage — availability across Europe

Availability information only — Mobi Doctor doesn't sell medicines; check with a pharmacy.

MEDICALLY REVIEWED
Dr. Chrysoula I. Liakou MD, PhD
Internal Medicine Specialist
Cancer Immunology Researcher
Reviewed 30 July 2026 · next review due 30 January 2027

Dibromopropamidine isethionate currently has availability issues reported in 1 European register: Ireland.

Shortage  ATC — · also listed as: Dibromopropamidine isethionate · data refreshed 13 September 2026

Key facts

As of 13 September 2026, 1 of the 9 tracked registers list current availability issues for Dibromopropamidine isethionate, covering 1 affected product presentation. The longest-running open report was filed in Ireland on 2022-11-16 and has now been open for about 46 months. Where agencies state a cause, manufacturing problems lead with 1 of the 1 stated-cause reports. The furthest expected-resolution date currently on file is 2027-01-02; the earliest is 2027-01-02. Registers in Ireland indicate that alternatives or equivalents are available — a pharmacist or doctor can advise on switching.

WhereStatus & productsSinceExpected end Reason / alternativesSource
🇮🇪 IrelandShortage
Golden Eye 0.15% w / w Eye Ointment
2022-11-162027-01-02Manufacturing delay (Ireland & UK)
Alternatives: Alternative(s) available — see the national register.
register ↗

Full report history (1 register entry)

Every individual register entry for Dibromopropamidine isethionate in the tracked sources, newest first — including resolved and discontinued reports.

Reg.ProductStatusReportedExpected endStated reason
🇮🇪 IEGolden Eye 0.15% w / w Eye OintmentShortage2022-11-162027-01-02Manufacturing delay (Ireland & UK)

Frequently asked

Is Dibromopropamidine isethionate currently in shortage in Europe?

Yes. As of 13 September 2026, availability issues are reported in: Ireland. Availability is national — a shortage in one country does not mean it is short everywhere.

When is the Dibromopropamidine isethionate shortage expected to end?

Agency prognoses on file range from 2027-01-02 to 2027-01-02. These are manufacturer-reported estimates and frequently move; check the linked register entry for the latest date.

Are there alternatives to Dibromopropamidine isethionate?

1 of the active register entries indicate alternatives or equivalents (same active substance or an alternative treatment). Do not switch on your own — a pharmacist or prescriber can confirm the right substitute in your country.

Where does this Dibromopropamidine isethionate availability data come from?

Directly from the official medicines-agency register that lists Dibromopropamidine isethionate: HPRA (Ireland). Every row on this page links to the underlying official record, and the dataset is refreshed from the primary sources every morning. Cross-language matching groups the same active substance across registers, so national spellings all resolve to this page.

Embed this tracker

Pharmacies, patient sites and newsrooms are welcome to embed the live status of Dibromopropamidine isethionate — free, with attribution. Copy this snippet:

<iframe src="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dibromopropamidine-isethionate/embed.html" width="100%" height="150" loading="lazy" style="border:1px solid #e1e0d9;border-radius:12px" title="Dibromopropamidine isethionate availability in Europe"></iframe>
<p style="font-size:12px">Source: <a href="https://www.mobidoctor.eu/medicine-shortages/medicine-shortages/dibromopropamidine-isethionate/">Dibromopropamidine isethionate shortage status — European Medicine Shortage Tracker</a> by MobiDoctor</p>
Cite: “Dibromopropamidine isethionate: availability status across 1 European registers — European Medicine Shortage Tracker (MobiDoctor), 13 September 2026.” Link this page and the agency record. Statuses come from the linked official registers and can change daily.